Movement disorders (dystonia, athetosis, chorée, ballism);Mouvements anormaux (dystonie, athétose, chorée, ballisme)

EMC - Neurologie

Volumn 1, Issue 1, 2004, Pages 3-41

  Vingerhoets, F ^a   Russmann, H ^a   Carruzzo, A ^a   Combremont, P ^a   Ghika, J ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Ballism; Basal ganglia; Chorea; Dystonia; Hyperkinetic movement disorders; Neurogenectic

Indexed keywords

EID: 33645708720     PISSN: 17624231     EISSN: 17624231     Source Type: Journal    
DOI: 10.1016/j.emcn.2003.10.006     Document Type: Short Survey

References (120)

1. Abbruzzese G, Rizzo F, Dall'Agata D, Morandi N, Favale E. Generalized dystonia with bilateral striatal computed-tomographic lucencies in a patient with human immunodeficiency virus infection. Eur Neurol 1990;30:271-273.
2. Agostino R, Berardelli A, Formica A, Accornero N, Manfredi M. Sequential arm movements in patients with Parkinson's disease, Huntington's disease and dystonia. Brain 1992;115(Pt 5):1481-1495.
3. Albin RL, Bromberg MB, Penney JB, Knapp R. Chorea and dystonia: a remote effect of carcinoma. Mov Disord 1988;3:162-169.
4. Albin RL, Tagle DA. Genetics and molecular biology of Huntington's disease. Trends in Neurosciences 1995;18:11-14.
5. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266-271.
6. Almasy L, Bressman SB, Raymond D, Kramer PL, Greene PE, Heiman GA, et al. Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families. Ann Neurol 1997;42:670-673.
7. Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The pathophysiology of primary dystonia. Brain 1998;121:1195-1212.
8. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994;117:859-876.
9. Bhatia KP, Soland VL, Bhatt MH, Quinn NP, Marsden CD. Paroxysmal exercise-induced dystonia: eight new sporadic cases and a review of the literature. Mov Disord 1997;12:1007-1012.
10. Bhatt MH, Obeso JA, Marsden CD. Time course of postanoxic akinetic-rigid and dystonic syndromes. Neurology 1993;43:314-317.
11. Brashear A, Butler IJ, Ozelius LJ, Kramer PI, Farlow MR, Breakefield XO, et al. Rapid-onset dystonia-parkinsonism: a report of clinical, biochemical, and genetic studies in two families. Adv Neurol 1998;78:335-339.
12. Breakefield XO, Kamm C, Hanson PI. TorsinA: movement at many levels. Neuron 2001;31:9-12.
13. Bressman SB. Dystonia update. Clin Neuropharmacol 2000;23:239-251.
14. Bressman SB, de Leon D, Kramer PL, Ozelius LJ, Brin MF, Greene PE, et al. Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation. Ann Neurol 1994;36:771-777.
15. Burbaud P, Berge J, Lagueny A, Mensire A, Melon M, Caille JM, et al. Delayed-onset hemidystonia secondary to herpes zoster ophthalmicus-related intracerebral arteritis in an adolescent. J Neurol 1997;244:470-472.
16. Burton K, Farrell K, Li D, Calne DB. Lesions of the putamen and dystonia: CT and magnetic resonance imaging. Neurology 1984;34:962-965.
17. Byl NN, Merzenich M, Jenkins WM. A primate genesis model of focal dystonia and repetitive strain injury: I. Learning-induced differentiation of the representation of the hand in the primary somatosensory cortex in adult monkeys. Neurology 1996;47:508-520.
18. Caparros-Lefebvre D, Destee A, Petit H. Late onset familial dystonia: could mitochondrial deficits induce a diffuse lesioning process of the whole basal ganglia system? J Neurol Neurosurg Psychiatry 1997;63:196-203.
19. Ceballos-Baumann AO, Passingham RE, Warner T, Playford ED, Marsden CD, et al. Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia. Ann Neurol 1995;37:363-372.
20. Chuang C, Fahn S, Frucht SJ. The natural history and treatment of acquired hemidystonia: report of 33 cases and review of the literature. J Neurol Neurosurg Psychiatry 2002;72:59-67.
21. Croteau D, Owainati A, Dalmau J, Rogers LR. Response to cancer therapy in a patient with a paraneoplastic choreiform disorder. Neurology 2001;57:719-722.
22. de Vries BB, Arts WF, Breedveld GJ, Hoogeboom JJ, Niermeijer MF, Heutink P. Benign hereditary chorea of early onset maps to chromosome 14q. Am J Hum Genet 2000;66:136-142.
23. DeLong MR. Primate models of movement disorders of basal ganglia origin. TINS 1990;13:281-285.
24. Deuschl G, Seifert G, Heinen F, Illert M, Lucking CH. Reciprocal inhibition of forearm flexor muscles in spasmodic torticollis. J Neurol Sci 1992;113:85-90.
25. Dewey RB, Jankovic J. Hemiballism-Hemichorea. Arch Neurol 1989;46:862-867.
26. Pooling EC, Schoene WC, Richardson Jr EP. HallervordenSpatz syndrome. Arch Neurol 1974;30:70-83.
27. Eidelberg D, Moeller JR, Antonini A, Kazumata K, Nakamura T, Dhawan V, et al. Functional brain networks in DYT1 dystonia. Ann Neurol 1998;44:303-312.
28. Factor SA, Friedmann JH. The emerging role of clozapine in the treatment of movement disorders. Mov Disord 1997;12:483-496.
29. Figueroa F, Berrios X, Gutierrez M, Carrion F, Goycolea JP, Riedel I, et al. Anticardiolipin antibodies in acute rheumatic fever. J Rheumatol 1992;19:1175-1180.
30. Garcia de Yebenes J, Sanchez Pernaute R, Tabernero C. Symptomatic dystonia. In: Watts RL, Koller WC, editors. Movement disorders. New York: McGraw Hill; 1997. p. 455-475.
31. Ghanem Q. Recurrent chorea gravidarum in four pregnancies. Can J Neurol Sci 1985;12:136-138.
32. Ghika J, Bogousslavsky J. Spinal pseudoathetosis: a rare, forgotten syndrome, with a review of old and recent descriptions. Neurology 1997;49:432-437.
33. Ghika J, Regli F, Growdon JH. Sensory symptoms in cranial dystonia: a potential role in etiology ? J Neurol Sci 1993;116:142-147.
34. Glass JP, Jankovic J, Borit A. Hemiballism and metastatic brain tumor. Neurology 1984;34:204-207.
35. Gledhill RF, Thompson PD. Standard neurodiagnostic tests in Sydenham's chorea. J Neurol Neurosurg Psychiatry 1990;53:534-535.
36. Gordon MF, Bressman S, Brin MF, de Leon D, Warburton D, Yeboa K, et al. Dystonia in a patient with deletion of 18q. Mov Disord 1995;10:496-499.
37. Goutieres F, Mikol J, Aicardi J. Neuronal intranuclear inclusion disease in a child: diagnosis by rectal biopsy. Ann Neurol 1990;27:103-106.
38. Grandas F, Artieda J, Obeso JA. Clinical and CT findings in a case of cyanide intoxication. Mov Disord 1989;4:188-193.
39. Greene P, Shale H, Fahn S. Analysis of open-label trials in torsion dystonia using high dosages of anticholinergic and other drugs. Mov Disord 1988;3:46-60.
40. Gusella JF, MacDonald ME, Ambrose CM, Duyao MP. Molecular genetics of Huntington's disease. Arch Neurol 1993;50:1157-1163.
41. Guttman M, Lang AE, Garnett ES, Nahmias C, Firnau G, Tyndel FJ, et al. Regional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea. Mov Disord 1987;2:201-210.
42. Hardie RJ, Pullon HW, Harding AE, Owen JS, Pires M, Daniels GL, et al. Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 1991;114:13-49.
43. Hattori H, Kawamori J, Takao T, Ito M, Nakano S, Okuno T, et al. Computed tomography in postinfluenzal encephalitis. Brain Dev 1983;5:564-567.
44. Hewett J, Gonzalez-Agosti C, Slater D, Ziefer P, Li S, Bergeron D, et al. Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum Mol Genet 2000;9:1403-1413.
45. Hitoshi S, Iwata M, Yoshikawa K. Mid-brain pathology of Wilson's disease: MRI analysis of three cases. J Neurol Neurosurg Psychiatry 1991;54:624-626.
46. Houser MK, Soland VL, Bhatia KP, Quinn NP, Marsden CD. Paroxysmal kinesigenic choreoathetosis: a report of 26 patients. J Neurol 1999;246:120-126.
47. Hwang WJ, Lu CS, Tsai JJ. Clinical manifestations of 20 Taiwanese patients with paroxysmal kinesigenic dyskinesia. Acta Neurol Scand 1998;98:340-345.
48. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology 1994;44:1533-1536.
49. Jankovic J. Post-traumatic movement disorders : central and peripheral mechanisms. Neurology 1994;44:2006-2014.
50. Jankovic J, Beach J. Long-term effects of tetrabenzine in hyperkinetic movement disorders. Neurology 1997;48:358-362.
51. Jankovic J, Fahn S. Dystonic disorders. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders. Baltimore: Williams and Wilkins; 1998. p. 513-551.
52. Jarman PR, Bhatia KP, Davie C, Heales SJ, Turjanski N, Taylor-Robinson SD, et al. Paroxysmal dystonic choreoathetosis: clinical features and investigation of pathophysiology in a large family. Mov Disord 2000;15:648-657.
53. Joel D. Open interconnected model of basal gangliathalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease. Mov Disord 2001;16:407-423.
54. Kaji R, Rothwell JC, Katayama M, Ikeda T, Kubori T, Kohara N. Tonic vibration reflex andmuscle afferent block in writer's cramp. Ann Neurol 1995;38:155-162.
55. Kirkwood SC, Siemers E, Bond C, Conneally PM, Christian JC, Foroud T. Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene. Arch Neurol 2000;57:1040-1044.
56. Klein C, Page CE, LeWitt P, Gordon MF, de Leon D, Awaad Y, et al. Genetic analysis of three patients with an 18p- syndrome and dystonia. Neurology 1999;52:649-651.
57. Kramer PL, Heiman GA, Gasser T, Ozelius LJ, de Leon D, Brin MF, et al. The DYT1 gene on 9q34 is responsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews. Am J Hum Genet 1994;55:468-475.
58. Krauss JK, Trankle R, Kopp KH. Post-traumatic movement disorders in survivors of severe head injury. Neurology 1996;47:1488-1492.
59. Kuemmerle S, Gutekunst CA, Klein AM, Li XJ, Li SH, Beal MF, et al. Huntington aggregates may not predict neuronal death in Huntington's disease. Ann Neurol 1999;46:842-849.
60. Kuwert T, Noth J, Scholz D, Schwarz M, Lange HW, Topper R, et al. Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease. Mov Disord 1993;8:98-106.
61. Lance JW. Familial paroxysmal dystonic choreoathetosis of Mount and Reback and its differentiation from related syndromes. Trans Am Neurol Assoc 1977;102:46-48.
62. Larsen TA, Dunn HG, Jan JE, Calne DB. Dystonia and calcification of the basal ganglia. Neurology 1985;35:533-537.
63. Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS. Saccades in Huntington's disease: slowing and dysmetria. Neurology 1988;38:427-431.
64. Lee BI, Lesser RP, Pippenger CE, Morris HH, Luders H, Dinner DS, et al. Familial paroxysmal hypnogenic dystonia. Neurology 1985;35:1357-1360.
65. Lee PH, Nam HS, Lee KY, Lee BI, Lee JD. Serial brain SPECT images in a case of Sydenham chorea. Arch Neurol 1999;56:237-240.
66. Ludolph AC, He F, Spencer PS, Hammerstad J, Sabri M. 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 1991;18:492-498.
67. MacMillan JC, Morrison PJ, Nevin NC, Shaw DJ, Harper PS, Quarrell OW, et al. Identification of an expanded CAG repeat in the Huntington's disease gene (IT15) in a family reported to have benign hereditary chorea. J Med Genet 1993;30:1012-1013.
68. Mao CC, Gancher ST, Herndon RM. Movement disorders in multiple sclerosis. Mov Disord 1988;3:109-116.
69. Marion MH. Traitement des dystonies. Presse Méd 1999;28:312-315.
70. Marsden CD. Clinical neurophysiology of muscle jerks. New York: Raven Press; 1983. p. 865-881.
71. Marsden CD, Marion MH, Quinn N. The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 1984;47:1166-1173.
72. Marsden CD, Obeso JA, Zarranz JJ, Lang AE. The anatomical basis of symptomatic hemidystonia. Brain 1985;108:463-483.
73. McFarlin DE, Strober W, Waldmann TA. Ataxiatelangiectasia. Medicine 1972;51:281-314.
74. Moore DP. Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review. J Clin Psychiatry 1996;57:407-414.
75. Muller U, Steinberger D, Nemeth AH. Clinical and molecular genetics of primary dystonias. Neurogenetics 1998;1:165-177.
76. Myers RH, Sax DS, Koroshetz WJ, Mastromauro C, Cupples LA, Kiely DK, et al. Factors associated with slow progression in Huntington's disease. Arch Neurol 1991;48:800-804.
77. Myers RH, Sax DS, Schoenfeld M, Bird ED, Wolf PA, Vonsattel JP, et al. Lote onset of Huntington's disease. J Neurol Neurosurg Psychiatry, 48. 1985. p. 530-534.
78. Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, Bundo M, et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet 1994;6:14-18.
79. Narayan RK, Louber PG, Jankovic J, Donovan WH, Bontke CF. Intrathecal baclofen for intractable axial dystonia. Neurology 1991;41:1141-1142.
80. Nygaard TG, Trugman JM, de Yebnes JG, Fahn S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 1990;40:66-69.
81. Nygaard TG, Wilhelmsen KC, Risch NJ, Brown DL, Trugman JM, Gilliam TC, et al. Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat Genet 1993;5:386-391.
82. Obeso JA, Gimenez-Roldan S. Clinicopathological correlation in symptomatic dystonia. Adv Neurol 1988;50:113-122.
83. Omdal R, Roalso S. Chorea gravidarum and chorea associated with oral contraceptives- diseases due to antiphospholipid antibodies? Acta Neurol Scand 1992;86:219-220.
84. Ozelius LJ, Hewett JW, Page CE, Bressman SB, Kramer PL, Shalish C, et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997;17:40-48.
85. Piccolo I, Causarano R, Sterzi R, Sberna M, Oreste PL, Moioli C, et al. Chorea in patients with AIDS. Acta Neurol Scand 1999;100:332-336.
86. Quinn NP. Parkinsonism and dystonia, pseudoparkinsonism and pseudodystonia. Adv Neurol 1993;60:540-543.
87. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 1988;85:5733-5737.
88. Reuter I, Hu MT, Andrews TC, Brooks DJ, Clough C, Chaudhuri KR. Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome. J Neurol Neurosurg Psychiatry 2000;68:238-241.
89. Robbins JH, Kraemer KH, Lutzner MA, Festoff BW, Coon HG. Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med 1974;80:221-248.
90. Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman JJ, et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996;59:16-22.
91. Russmann H, Vingerhoets F, Ghika J, Maeder P, Bogousslavsky J. Acute infarction limited to the putamen and globus pallidus; clinical, etiologic and topographic features. Arch Neurol 2003;60:351-355.
92. Sakai T, Mawatari S, Iwashita H, Goto I, Kuroiwa Y, Choreoacanthocytosis. Clues to clinical diagnosis. Arch Neurol 1981;38:335-338.
93. Scheinberg IH. The central nervous system, clinical neurology. Wilson's disease. Philadelphia: WB Saunders; 1984. p. 78-85.
94. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 1997;90:549-558.
95. Scott BL, Jankovic J. Delayed-onset progressive movement disorders after static brain lesions. Neurology 1996;46:68-74.
96. Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976;14:215-233.
97. Seiser A, Schwarz S, Aichinger-Steiner MM, Funk G, Schnider P, et al. Parkinsonism and dystonia in central pontine and extrapontine myelinolysis. J Neurol Neurosurg Psychiatry 1998;65:119-121.
98. Sethi KD, Hess DC. Creutzfeldt-Jakob's disease presenting with ataxia and a movement disorder. Mov Disord 1991;6:157-162.
99. Shinotoh H, Calne DB, Snow B, Hayward M, Kremer B, Theilmann J, et al. Normal CAG repeat length in the Huntington's disease gene in senile chorea. Neurology 1994;44:2183-2184.
100. Stacy M, Cardoso F, Jankovic J. Tardive stereotypy and other movement disorders in tardive dyskinesias. Neurology 1993;43:937-941.
101. Svetel M, Kozic D, Stefanova E, Semnic R, Dragasevic N, Kostic VS. Dystonia in Wilson's disease. Mov Disord 2001;16:719-723.
102. Swaiman KF. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 1991;48:1285-1293.
103. Swedo SE. Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA 1994;272:1788-1791.
104. Swerdlow RH, Wooten GF. A novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr-Tranebjaerg syndrome. Ann Neurol 2001;50:537-540.
105. Takahashi H, Ohama E, Suzuki S, Horikawa Y, Ishikawa A, Morita T, et al. Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology 1994;44:437-441.
106. Tegenthoff M, Vorgerd M, Juskowiak F, Roos V, Malin JP. Postexcitatory inhibition after transcranial magnetic single and double brain stimulation in Huntington's disease. Electroencephalogr Clin Neurophysiol 1996;101:298-303.
107. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-983.
108. Tsui JK, Bhatt M, Calne S, Calne DB. Botulinum toxin in the treatment of writer's cramp: a double-blind study. Neurology 1993;43:183-185.
109. Turjanski N, Weeks R, Dolan R, Harding AE, Brooks DJ. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. Brain 1995;118(Pt 3):689-696 A PET study.
110. Valente EM, Bentivoglio AR, Cassetta E, Dixon PH, Davis MB, Ferraris A, et al. DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13-36.32 in an Italian family with cranial-cervical or upper limb onset. Ann Neurol 2001;49:362-366.
111. Vanek Z, Jankovic J. Dystonia in corticobasal degeneration. Mov Disord 2001;16:252-257.
112. Veasy L, Tani L, Hill H. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 1994;124:9-16.
113. Venegas P, Miranda M, Delgado C. Bilateral striato-pallidaldentate calcification. Rev Neurol 2001;33:198-200 Presentation as a speech dystonia.
114. Vercueil L, Pollak P, Fraix V, Caputo E, Moro E, Benazzouz A, et al. Deep brain stimulation in the treatment of severe dystonia. J Neurol 2001;248:695-700.
115. Vidailhet M, Tassin J, Durif F, Nivelon-Chevallier A, Agid Y, Brice A, et al. A major locus for several phenotypes of myoclonus-dystonia on chromosome 7q. Neurology 2001;56:1213-1216.
116. Vitek JL, Chockkan V, Zhang JY, Kaneoke Y, Evatt M, DeLong MR, et al. Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. Ann Neurol 1999;46:22-35.
117. Warren JD, Firgaira F, Thompson EM, Kneebone CS, Blumbergs PC, Thompson PD. The causes of sporadic and 'senile' chorea. Aust N Z J Med 1998;28:429-431.
118. Weiner WJ, Klawans Jr HL Lingual-facial-buccal movements in the elderly. II. Parthogenesis and relationship to senile chorea. J Am Geriatr Soc 1973;21:318-320.
119. Wooten GF, Lopes MB, Harris WO, Reagan TJ, Vandenberg SR. Pallidoluysian atrophy: dystonia and basal ganglia functional anatomy. Neurology 1993;43:1764-1768.
120. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 2001;293:493-498.